6
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Similarity of Central and Peripheral Alpha-1 Adrenoceptors in Rat and Rabbit

, , , &
Pages 743-759 | Published online: 26 Sep 2008

References

  • Clark W. R., Jones L. R., Lefkowitz R. J. Hepatic α-adrenergic receptors. Identification and subcellular localization using [3H]-dihydroergocryptine. J. Biol. Chem. 1978; 253: 5975–5979
  • U'Prichard D. C., Greenberg D. A., Snyder S. H. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha nonadrenergic receptors, Mol. Pharmacol. 1977; 13: 454–473
  • Bylund D. B., U'Prichard D. C. Characterization α1-and α2-adrenergic receptors. Int. Rev. Neurobiol. 1983; 24: 343–431
  • Bickerton R. K. The response of isolated strips of cat spleen to sympathomimetic drugs and their antagonists. xsJ. Pharmacol. Exp. Ther. 1963; 142: 99–110
  • Hoffman B. B., Michael T., Mullikin-Kilpatrick D., Lefkowitz R. J., Tolbert M. E.M., Gilman H., Fain J. N. Agonist versus antagonist binding to α-adrenergic receptors, Proc. Natl. Acad. Sci. USA 1980; 77: 4569–4573
  • Schmitt H., Fenard S. Effets des substances sympathomimetiques sur les centres vasomoteurs, Arch. Int. Pharmacodyn. Ther. 1971; 190: 229–240
  • Swain T. Biochemical evolution in plants. Comprehensive Biochemistry, M. Florkin, E. H. Stotz. Elsevier, New York, NY 1974; Vol. 29: 163–171
  • Inagami T., Chang J. J., Dykes C. W., Takii Y., Kisaragi M., Misano K. S. Renin: Structural features of active enzyme and inactive precursor. Federation Proc. 1983; 42: 2729–2734
  • Sheys E. M., Green R. D. A quantitative study of alpha adrenergic receptors in the spleen and aorta of the rabbit. J. Pharmacol. Exp. Ther. 1972; 180: 317–325
  • Ruffolo R. R., Jr., Waddell J. E. Receptor interactions of imidazolines: alpha-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists. Br. J. Pharmacol. 1982; 77: 169–176
  • Ruffolo R. R., Waddell J. E., Yaden. Heterogeneity of postsynaptic alpha adrenergic receptors in mammalian aortas. J. Pharmacol. Exp. Ther. 1982; 221: 309–314
  • Purdy R. E., Ashbrook D. W., Stupecky G. L., Watanabe M. Y. Qualitative and quantitative differences between postsynaptic alpha adrenoceptors of rabbit ear artery and thoracic aorta. J. Pharmacol. Exp. Ther. 1983; 224: 543–551
  • Digges K. G., Summers R. J. Characterization of postsynaptic α-adrenoceptors in rat aortic strips and portal veins. Br. J. Pharmacol. 1983; 79: 655–665
  • DeJonge A., Timmermans P. B.M.W.M., vanZwieten P. A. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolines. III. Comparison of central and peripheral alpha-1 and alpha-2 adrenoceptors. J. Pharmacol. Exp. Ther. 1983; 226: 565–571
  • Stephenson R. P. A modification of receptor theory, Br. J. Pharmacol. 1956; 11: 379–393
  • Hieble J. P., Sarau H. M., Foley J. J., DeMarinis R. M., Pendleton R. G. Comparison of central and peripheral alpha-1 adrenoceptors, Naunyn-Schmiedeberg's. Arch. Pharmacol. 1982; 318: 267–273
  • Minneman K. P., Fox A. W., Abel P. W. Occupancy of alpha-1 adrenergic receptors and contraction of rat vas deferens. Mol. Pharmacol. 1983; 23: 359–368
  • Minneman K. P. Binding properties of alpha-1 adrenergic receptors in rat cerebral cortex: Similarity to smooth muscle. J. Pharmacol. Exp. Ther. 1983; 227: 605–612
  • Chapleo C. B., Myers P. L., Butler R. C.M., Davis J. A., Doxey J. C., Higgins S. D., Myers M., Roach A. G., Smith C. F.C., Stillings M. R., Welbourn A. P. α-Adrenoceptor reagents. 2. Effects of modification of the 1, 4-benzodioxan ring system on α-adrenoceptor activity. J. Med. Chem. 1984; 27: 570–576
  • Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–254
  • Scatchard G. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 1949; 51: 660–672
  • Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980; 107: 220–239
  • Cheng Y.-C., Prusoff W. H. Relationship between the inhibition constant (KI)and the concentration of inhibitor which causes 50 persent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
  • Fleming W. W., Westfall D. P., DeLaLande I. S., Jellett L. B. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 1972; 181: 339–345
  • DeLean A., Hancock A. A., Lefkowitz R. J. Validation and statistical analysis of a computer method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 1982; 21: 5–16
  • Berthelsen S., Pettinger W. A. A functional basis for classification of alpha-adrenergic receptors. Life Sciences 1977; 21: 595–606
  • Cavero I., Lefevre-Borg F., Roach A. G., Gomeni R., Scatton B. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats. J. Pharmacol. Exp. Ther. 1982; 223: 241–250
  • Greengrass P., Bremner R. Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors, Eur. J. Pharmacol. 1979; 55: 323–326
  • Hornung R., Presek P., Glossman H. Alpha adrenoceptors in rat brain: direct identification with prazosin, Naunyn-Schmiedeberg's. Arch. Pharmacol. 1979; 308: 223–230
  • U'Prichard D. C., Snyder S. H. Distinct α-noradrenergic receptors differentiated by binding and physiological relationships. Life Sciences 1979; 24: 79–88
  • Timmermans P. B.M.W.M., Qian J. Q., Ruffolo R. R., Jr., vanZwieten P. A. A study of the selectivity and potency of rauwolscine, RX781094 and RS21361 as antagonists of alpha-1 and alpha-2 adrenoceptors. J. Pharmacol. Exp. Ther. 1984; 228: 739–748
  • Hoffman B. B., Dukes D. F., Lefkowitz R. J. Alpha-adrenergic receptors in liver membranes: Delineation with subtype selective radioligands. Life Sciences 1981; 28: 265–272

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.